NEW YORK, May 16 (GenomeWeb News) - Shares in Solexa were down 12.54 percent, or $.74, at $5.16 in mid-afternoon trading after the company today said its outside auditor had raised doubts about the firm's ability to remain in business through "at least" the end of the year.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.